Clinical Trials

LymphoidOther hematologic neoplasm

36 enrolled

Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Lymphoid, Lymphatic Diseases, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06075849 2024-02-23

Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent

30 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT05591053 2024-02-21

Utility and Usability of ActivSight™ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans

70 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Diseases, Esophageal Neoplasms, Neoplasms

NCT03549273 2024-02-07

Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions

62 enrolled

Gynecologic

Carcinoma, Uterine Cervical Dysplasia, Neoplasms, Neoplasms, Glandular and Epithelial

NCT04149691 2024-02-07

Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies

GastrointestinalGenitourinaryGynecologicSarcoma

42 enrolled

Urinary Bladder Neoplasms, Carcinoma, Neoplasms, Sarcoma, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT05675605 2024-01-30

A Study of TY-1091 in Patients With Advanced Solid Tumors

248 enrolled

Neoplasms, Carcinoma, Medullary

NCT06173011 2024-01-23

A Study Comparing Pharmacokinetic and Safety of QL2107 and Keytruda® (Marketed in China and the United States) in Healthy Adults

168 enrolled

Neoplasms

NCT06183151 2023-12-27

CaVe

150 enrolled

Neoplasms

NCT06175780 2023-12-26

Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors

189 enrolled

Neoplasms, Neoplasms by Histologic Type

NCT06134245 2023-11-18

HOUSE

100 enrolled

Neoplasms

NCT05453604 2023-11-13

URODETECT-WP1

105 enrolled

BreastGenitourinary

Breast Neoplasms, Neoplasms, Prostatic Neoplasms

NCT04343859 2023-11-09

A Study of IMMH-010 in Patients With Advanced Malignant Solid Tumors

96 enrolled

Neoplasms

NCT05094804 2023-11-02

A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents

DermatologicHead & NeckSarcomaThoracic

172 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Leiomyosarcoma, Liposarcoma, Melanoma, Neoplasm Metastasis, Neoplasms

NCT06092606 2023-10-23

A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients

90 enrolled

Arrhythmias, Cardiac, Heart Failure, Neoplasms

NCT05498597 2023-10-19

AMT-151 in Patients With Selected Advanced Solid Tumours

BreastGynecologicOther solid neoplasmThoracic

30 enrolled

Adenocarcinoma of Lung, Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Carcinoma, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06055543 2023-09-26

Impact of a New Plant-based High-energy Oral Nutritional Supplement on Nutritional Outcomes in Malnourished Patients

Phase 4 Unknown

140 enrolled

Acquired Immunodeficiency Syndrome, Neoplasms, Inflammatory Bowel Diseases, Pulmonary Disease, Chronic Obstructive, Malnutrition

NCT02889978 2023-09-13

CCGA

15,254 enrolled

Neoplasms

NCT05296772 2023-09-06

Phase 1 First-in-human Study of JS014

60 enrolled

Lymphoid

Lymphoma, Neoplasms, Neoplasms, Experimental

NCT05964543 2023-07-28

The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors

72 enrolled

Adenocarcinoma, Neoplasms

NCT05708950 2023-07-13

A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

314 enrolled

Breast Neoplasms, Carcinoma, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Uterine Neoplasms

NCT03797391 2023-05-31

A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors

186 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms

NCT03820310 2023-05-24

Clinical Trial of Autologous Tcm Immunotherapy in ICC

20 enrolled

Gastrointestinal

Neoplasms, Cholangiocarcinoma

NCT05870449 2023-05-23

PICC

1,666 enrolled

Infections, Neoplasms, Phlebitis, Thrombosis

NCT05338073 2023-04-24

KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models

2,000 enrolled

Neoplasms

NCT05539157 2023-04-04

Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors

1 enrolled

Dermatologic

Neoplasms, Skin Neoplasms

NCT05453591 2023-03-24

URODETECT-WP3

200 enrolled

Breast

Breast Neoplasms, Neoplasms

NCT03561259 2023-02-16

OPTIMUM

60 enrolled

CNS

Neoplasms, Neuroblastoma, Neuroectodermal Tumors

NCT04309084 2023-02-16

Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

29 enrolled

LymphoidPlasma cell

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Neoplasm, Residual, Hemostatic Disorders, Neoplasms, Plasma Cell

NCT03793088 2023-02-03

XCELSIOR

10,000 enrolled

CNS

Glioblastoma, Glioma, Neoplasms

NCT01972867 2023-02-01

Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients

6 enrolled

Genitourinary

Neoplasms, Prostatic Neoplasms

NCT05272865 2023-02-01

Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC

334 enrolled

Cancer Pain, Neoplasms, Vomiting

NCT05704894 2023-01-30

Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens

Phase 3 Unknown

320 enrolled

Classical hematology

Anemia, Neoplasms

NCT05700370 2023-01-26

MyProstateScore Equivalency With and Without DRE

800 enrolled

Genitourinary

Neoplasms, Prostatic Neoplasms

NCT05693831 2023-01-23

myCare-102

730 enrolled

Neoplasms, Recurrence

NCT04900519 2023-01-17

Study of the Safety and Efficacy of STI-6643 in Subjects With Advanced Solid Tumors

100 enrolled

Neoplasms

NCT05685524 2023-01-17

Clinical Study of Pan-cancer DNA Methylation Test in Plasma

GastrointestinalGenitourinaryGynecologicHead & NeckThoracic

3,000 enrolled

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT05650385 2022-12-14

A Study of B1962, a PD-L1/VEGF Bispecific Antibody Fusion Protein, for Advanced Solid Tumors

68 enrolled

Neoplasms

NCT05647785 2022-12-12

Long-term Follow-up of RESTORE Study

350 enrolled

Neoplasms

NCT05645653 2022-12-09

Nurse-led Medication Self-management Intervention in the Improvement of Medication Adherence

100 enrolled

Head & Neck

Asthma, Diabetes Mellitus, Heart Diseases, Hypertension, Neoplasms, Thyroid Diseases

NCT05416710 2022-12-07

UNITY

1,000 enrolled

Neoplasms

NCT03142204 2022-12-05

[18F]FAraG PET Imaging for Analysis of Biodistribution in Cancer Patients Expected to Undergo Immunotherapy and/or Radiation Therapy

30 enrolled

Neoplasms

NCT05291390 2022-11-29

Pyronaridine in Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML)

LymphoidOther hematologic neoplasm

200 enrolled

Leukemia, Neoplasms, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05080907 2022-11-09

Collection and Distribution of Biospecimens for Novel Research

100,000 enrolled

Autoimmune Diseases, Communicable Diseases, Hematologic Diseases, Neoplasms, Skin Diseases

NCT03491631 2022-11-04

Phase I Study of SHR9146 + SHR-1210 +/- Apatinib in Patients With Advanced Solid Tumors

23 enrolled